NZ's TruScreen rises as cancer screening device results in China exceed expectations

Truscreen

02/09/2019 02:24

** Shares of TruScreen Ltd  TRU.NZ  rise as much as 2.7% to
A$0.113, their highest since Aug 21
    ** Cervical cancer screening technology co says screening
results from 2,065 women across 7 hospitals in Hunan, China
exceed expectations  urn:newsml:reuters.com:*:nNZShhga
    ** The cervical cancer screening device demonstrates
"improved sensitivity and specificity targeting pre-cancerous
and cancerous cervical cells"- Co
    ** Over 427,000 shares change hands, compared with the
30-day average volume of 120,673
    


 (Reporting by Shruti Sonal in Bengaluru)
 ((Shruti.Sonal@thomsonreuters.com;))